The Jack Quaid-starring action-comedy topped the leaderboard in the slowest weekend at the box office so far this year.

The Warner Bros. film, starring Robert Pattinson, still won the weekend despite coming in on the lower end of expectations.

The Jack Quaid-led action comedy "Novocaine" will vie with last weekend's champion "Mickey 17" for the top spot on box office charts.

Making a film that wins Best Picture earns a filmmaker a whole lot of industry clout when it comes to making their next project, and in the case of Bong Joon Ho, he swung big. Based on the book Mickey 7 by author Edward Ashton,

Mickey 17” — "Parasite" director Bong Joon Ho’s sci-fi comedy starring Robert Pattinson — is off to a rough start at the domestic box office.

Greenlit in January 2022 under previous Warner film chairman Toby Emmerich, “Mickey 17” is acclaimed director Bong Joon-ho’s follow-up to his Best Picture Oscar winner “Parasite” and carries a reported production budget of $118 million.

Bong Joon Ho’s “Mickey 17,” the first of Warner Bros.’ eclectic, pricey 2025 slate of original films from name-brand directors like Ryan Coogler and Paul Thomas Anderson, isn’t getting the warmest arrival at the box office.

Wait, wasn’t the impact from the strikes last year? If 2025 is going to be known for anything, it’s which weekend is the lowest at the box office. With Paramount’s new wide entry Novocaine and Warner Bros’ Mickey 17 doing about $8M each (many believe the Jack Quaid movie has the edge),

A mid-March weekend at the box office is supposed to be a busy one with spring break beginning and four-quadrant films on offer. But the film industry is in such a terrible slump that Paramount's R-rated action comedy "Novocaine" was able to take No.

Jack Quaid’s action-comedy “Novocaine” topped a painfully slow weekend at the box office with $8.7 million. For theater owners, however, there’s not too much to celebrate: It’s one of the worst debuts to still capture the No.